Clinical Trial Update: Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 clinical trial evaluating omega-3 polyunsaturated fatty acids in patients with severe chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Omega-3 Polyunsaturated Fatty Acids (N3-Pufa) (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Medical University of Vienna | Conditions: Chronic Heart Failure | Phase 2, Phase 3 | Status: COMPLETED